The New York Entrepreneur

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

Read Time:8 Second

The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Eurozone second quarter GDP rises 0.3%, up 0.6% for year
Next post Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda